©The Author(s) 2025.
World J Cardiol. Nov 26, 2025; 17(11): 109287
Published online Nov 26, 2025. doi: 10.4330/wjc.v17.i11.109287
Published online Nov 26, 2025. doi: 10.4330/wjc.v17.i11.109287
Table 1 General data on the included patients, n (%)
| Characteristic | Overall (n = 128) | Observation group (n = 55) | Control group (n = 73) | P value |
| Age (year), mean ± SD | 63 ± 10 | 62 ± 11 | 64 ± 6 | 0.42 |
| Male | 95 (74) | 40 (73) | 67 (92) | 0.09 |
| Type of lesion | 0.71 | |||
| Non-STEMI | 95 (74) | 40 (73) | 55 (76) | |
| STEMI | 33 (26) | 15 (27) | 18 (24) | |
| Heart rate (bpm), mean ± SD | 72 ± 16 | 71 ± 16 | 72 ± 17 | 0.01 |
| Systolic pressure (mmHg), mean ± SD | 114 ± 21 | 114 ± 20 | 119 ± 22 | 0.27 |
| Diastolic pressure (mmHg), mean ± SD | 73 ± 16 | 71 ± 9 | 76 ± 7 | 0.14 |
| Left ventricular ejection fraction (%), mean ± SD | 47 ± 10 | 47 ± 10 | 47 ± 11 | 0.47 |
| Creatinine (mmol/L), mean ± SD | 72 ± 22 | 72 ± 24 | 79 ± 10 | 0.21 |
| Pulmonary arterial hypertension | 15 (12) | 6 (11) | 9 (12) | 0.62 |
| Diabetes mellitus | 22 (17) | 9 (16) | 13 (18) | 0.76 |
| Dyslipidemia | 42 (33) | 17 (31) | 25 (34) | 0.22 |
| Smoking | 42 (33) | 24 (44) | 18 (25) | 0.62 |
| Family history of coronary artery disease | 44 (34) | 19 (35) | 25 (34) | 0.42 |
| Antithrombotics | ||||
| Aspirin | 92 (72) | 34 (62) | 58 (79) | - |
| Clopidogrel | 46 (36) | 20 (36) | 26 (36) | 1.00 |
| Direct oral anticoagulant | 6 (5) | 2 (4) | 4 (5) | 0.42 |
- Citation: Li J, Li XR, Kong MW, Zhang J. Medium-to-long term outcomes of bioresorbable scaffold treatment in patients with acute coronary syndrome. World J Cardiol 2025; 17(11): 109287
- URL: https://www.wjgnet.com/1949-8462/full/v17/i11/109287.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i11.109287